PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.34
Similar ESG score to SAVA's 61.69. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
58.68
Environmental score 90-95% of SAVA's 63.88. Bill Ackman would demand clear environmental improvement catalysts.
58.17
Social score 90-95% of SAVA's 61.93. Bill Ackman would demand clear social improvement catalysts.
61.16
Similar governance score to SAVA's 59.27. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.